stockrowH. B. Fuller Company
FUL Basic Materials Specialty Chemicals
H. B. Fuller Company’s revenue for fiscal 2025 (year ended November 2025) was $3.5 billion, down 2.67% from fiscal 2024.
- Revenue
- +5.17%
- EPS
- +18.2%
- Free cash flow
- −58.4%
- Total debt
- −1.25%
Quarter to August 2026, against a year earlier
Follow FUL
Alert me
H. B. Fuller Company (FUL) Total debt
H. B. Fuller Company's total debt at the end of fiscal 2025 was $2.0B, unchanged from fiscal 2024. At the end of the quarter to 31 August 2026 it was $2.1B. Over the past ten years it has ranged from $665.9M (fiscal 2016) to $2.4B (fiscal 2017); the current reading is higher than 82% of that period. H. B. Fuller Company ranks 19th of 60 Specialty Chemicals companies by total debt.
Total debt, annual
Embed this chart
Annual newest first
| Period | Total debt | Change |
|---|---|---|
| FY2025 | $2.0B | 0.34% |
| FY2024 | $2.0B | 9.44% |
| FY2023 | $1.8B | 5.78% |
| FY2022 | $1.7B | 9.10% |
| FY2021 | $1.6B | (9.42%) |
| FY2020 | $1.8B | (10.51%) |
| FY2019 | $2.0B | (12.06%) |
| FY2018 | $2.2B | (7.75%) |
| FY2017 | $2.4B | 263.46% |
| FY2016 | $665.9M | (3.78%) |
Quarterly newest first
| Period | Total debt | Change |
|---|---|---|
| Aug 2026 | $2.1B | (0.85%) |
| May 2026 | $2.1B | (0.19%) |
| Feb 2026 | $2.1B | 2.93% |
| Nov 2025 | $2.0B | (3.05%) |
| 43 more quarters | Free account |
Against its own ten years
Total debt against peers
| Company | Total debt |
|---|---|
| CC The Chemours Company compare | $3.8B |
| CLMT Calumet, Inc. compare | $2.7B |
| FUL H. B. Fuller Company | $2.1B |
| ASH Ashland Inc. compare | $1.4B |
| CBT Cabot Corporation compare | $1.3B |
| NGVT Ingevity Corporation compare | $1.1B |
| KWR Quaker Houghton compare | $892.0M |
| HWKN Hawkins, Inc. compare | $229.0M |
| WDFC WD-40 Company compare | $86.0M |
What Total debt is
Total Debt tells an investor how much a company has borrowed in all, whether the money is due within a year or later.
Long Term Debt (Total) + Current Part of Debt
More on FUL
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement